Laboratoires (ALEMG) | Stock Overview & Key Data
Laboratoires Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €28.40 on February 24, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Laboratoires ALEMG | 12.05M Small-cap | -0.22% | 21.72% | 28.98% | 0.89% | 3.42% | 3.42% | -13.22% | -50.76% |
| Bastide le Confort BLC | 223.19M Mid-cap | -0.16% | 12.37% | 26.69% | 33.33% | 35.32% | 57.88% | -2.88% | -17.29% |
| Metrics In Balance MLMIB | 790.30K Small_cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -70.00% | -94.64% | -98.97% |
| bioMérieux S.A BIM | 14.19B Large-cap | 1.45% | -1.65% | 3.66% | 13.01% | 15.87% | 24.36% | 12.40% | -10.04% |
| Eurofins Scientific ERF | 10.59B Large-cap | -1.81% | 1.95% | 26.63% | 23.82% | 22.37% | 22.97% | -23.56% | 7.84% |
| Ipsen S.A IPN | 8.36B Large-cap | -0.19% | -0.77% | 3.93% | -12.17% | -8.75% | -8.15% | 9.51% | 29.01% |
Ownership & Short Interest
Laboratoires Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Laboratoires would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Laboratoires reached a high of €6.60 (on August 19, 2024) and a low of €3.39 (on April 8, 2025).
Curious about Laboratoires's size and valuation? Its market capitalization stands at 12.05M. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.13, and the forward P/E (looking ahead) is 10.55.
As for dividends, Laboratoires isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Laboratoires, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Bastide le Confort
BLC223.19M Healthcare Medical Distribution 57.88% -2.88% Metrics In Balance
MLMIB790.30K Healthcare Medical Distribution -70.00% -94.64% bioMérieux S.A
BIM14.19B Healthcare Diagnostics & Research 24.36% 12.40% Eurofins Scientific
ERF10.59B Healthcare Diagnostics & Research 22.97% -23.56% Ipsen S.A
IPN8.36B Healthcare Drug Manufacturers - Specialty & Generic -8.15% 9.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of Laboratoires's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -31.26%, the Debt to Equity ratio from the most recent quarter is 48.76, and its Gross Profit Margin stands at N/A.
Looking at Laboratoires's growth, its revenue over the trailing twelve months (TTM) was €36M. Compared to the same quarter last year (YoY), quarterly revenue grew by 93.50%, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Laboratoires stock? Company insiders (like executives and directors) hold about 64.33% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.67%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.